Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
pancreatic cancer glutathione enhancement

pancreatic cancer glutathione enhancement Novel drug therapy kills cells by reducing levels of antioxidants Navigating the complexities of ferroptosis

Navigating the complexities of ferroptosis in pancreatic ductal adenocarcinoma: roles, mechanisms and potential applications Cell Death Discovery Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment Frontiers Integrated Analysis of Glutathione Metabolic Pathway in Pancreatic Cancer Leveraging glycosylation for early detection and therapeutic target discovery in pancreatic cancer Cell Death & Disease Beyond the tumor: Enhancing pancreatic cancer therapy through glutamine metabolism and innovative drug delivery Su 2025 Journal of Cell Communication and Signaling Wiley Online Library

SKU: 1540536494 · From crisbcreativa.com

4.1
USD29.36 USD68.36

Pay in 4 interest-free payments of $7.34 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

doi: 10.1038/cddis.2014.569 196 FengACThomasBJPurbeyPKde MeloFMLiuXDalyAEet al

pancreatic cancer glutathione enhancement Novel drug therapy kills cells by reducing levels of antioxidants Navigating the complexities of ferroptosis

Cell lines were procured form ATCC and included HCT116 (CCL-247), Ca Ski (CRL-1550), SJSA-1 (CRL-2098), A549(CCL-185), Hep G2 (HB-8065), MCF-7 (HTB-22), LoVo (CCL-229), SW48 (CCL-231), SW480(CCL-228), AsPC-1(CRL-1682), HL-60 (CCL-240), LS123 (CCL-255), MDA-MB-361 (HTB-27), MIA PaCa-2 (CRL-1420), HeLa (CCL-2), MS571 (HTB-34), SiHa (HTB-35), NCI-H1299 (CRL-5803), and Saos-2 (HTB-85)

pancreatic cancer glutathione enhancement Novel drug therapy kills cells by reducing levels of antioxidants Navigating the complexities of ferroptosis

Try MacroFactor for free with code WITSANDWEIGHTS

pancreatic cancer glutathione enhancement Novel drug therapy kills cells by reducing levels of antioxidants Navigating the complexities of ferroptosis

Cytokine-targeted therapy focuses on IL- 1, employing neutralizing antibodies or receptor antagonists to block its signaling pathway, which helps alleviate inflammatory responses and preserve blood-brain barrier integrity (206)

pancreatic cancer glutathione enhancement Novel drug therapy kills cells by reducing levels of antioxidants Navigating the complexities of ferroptosis

Inhibition of BCL2 family members increases the efficacy of copper chelation in BRAF(V600E)-driven melanoma

pancreatic cancer glutathione enhancement Novel drug therapy kills cells by reducing levels of antioxidants Navigating the complexities of ferroptosis
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products